Almach Bio Overview
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
1
Almach Bio General Information
Description
Developer of cell therapies designed to help transplant recipients achieve immune tolerance and reduce dependence on anti-rejection drugs. This company is currently operating in Stealth mode.
Contact Information
Website
www.almachbio.comCorporate Office
- Berkeley, CA
- United States
Corporate Office
- Berkeley, CA
- United States
Almach Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 01-Jan-2026 | Completed | Stealth |
Almach Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Almach Bio Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| NPU Ventures | Venture Capital | Minority |
Almach Bio FAQs
-
Where is Almach Bio headquartered?
Almach Bio is headquartered in Berkeley, CA.
-
What industry is Almach Bio in?
Almach Bio’s primary industry is Biotechnology.
-
Is Almach Bio a private or public company?
Almach Bio is a Private company.
-
What is Almach Bio’s current revenue?
The current revenue for Almach Bio is .
-
Who are Almach Bio’s investors?
NPU Ventures has invested in Almach Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
